Alma Media Corporation Stock Exchange Release November 20, 2015 at 4.30 pm (EET) ANNOUNCEMENT UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKETS ACT: MARIATORP OY’S SHAREHOLDING IN ALMA MEDIA CORPORATION Alma Media Corporation has received on 20 November 2015 an announcement pursuant to section 10, chapter 9, of the Securities Markets Act from Mariatorp Oy, that the agreement it announced on 12 November has been carried through, and that due to the increase in Alma Media’s number of shares as a result of the completion of the exchange offer on Talentum’s shares, Mariatorps’ holding of the shares and votes in Alma Media has fallen below the threshold of 20%. Issuing company and its business ID: Alma Media Corporation, 1944757-4 Complete name and business ID of the shareholder: Mariatorp Oy, 2690035-7 Basis of announcement: Acquisition or disposal of shares or voting rights and the rise of issuing company’s number of shares. Date of transaction and exceeding the threshold: 20.11.2015 Below threshold: 1/5 (20%) of shares and votes Holding of Mariatorp Before change in holding: Number of Alma Media Corporation shares 15,474,774 Percentage of shares and votes 20.50 % After the change in holding: Number of Alma Media Corporation shares 15,474,774 Percentage of shares and votes 18.78 % The registered number of the Alma Media Corporation shares is 82 383 182 shares, which entitle to a total of 82 383 182 votes. ALMA MEDIA CORPORATION Rauno Heinonen Vice President, Corporate Communications and IR Further information: Mikko Korttila, General Counsel, tel. +358 (0)10 665 2201 Distribution: NASDAQ OMX Helsinki Ltd, Main Media, www.almamedia.fi Alma Media in brief Alma Media is a media company focusing on digital services and publishing. In addition to news services, the company’s products provide useful information related to lifestyle, career and business development. The services of Alma Media have expanded from Finland to the Nordic countries, the Baltics and Central Europe. In 2014, the company employed an average of 1,830 professionals (excluding deliverers), of whom approximately one quarter worked outside Finland. Alma Media’s revenue in 2014 totalled approximately EUR 295 million. Alma Media’s share is listed on NASDAQ OMX Helsinki. Read more at www.almamedia.com.
ANNOUNCEMENT UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Triumph Financial Sets Stage for Q4 Earnings and Insights
Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...
Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide
The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...
Continue Reading
Understanding Dowlais Group's Recent Market Activities
Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r
Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024
OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...
Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma
HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...
Continue Reading